University of Leicester researchers have developed ONCO-ACS, an AI-powered model to predict mortality, bleeding, and ischaemic events in cancer patients after heart attacks.
Key Details
- 1ONCO-ACS is an AI model combining cancer-related and standard clinical data to predict death, bleeding, or cardiovascular events within six months post-heart attack.
- 2The study analyzed data from over 1 million heart attack patients, including more than 47,000 with cancer, from England, Sweden, and Switzerland.
- 3Results showed nearly one in three cancer patients died within six months, one in 14 suffered major bleeding, and one in six had another cardiovascular event.
- 4The model is published in The Lancet and funded by Cancer Research UK and the British Heart Foundation.
- 5The tool aims to guide personalized treatment decisions and design future trials for this complex patient group.
Why It Matters
This model addresses a significant clinical gap by offering tailored risk assessment for cancer patients post-heart attack, a group with limited guidance so far. Its real-world data approach and integration potential could improve patient outcomes and inform more precise treatment strategies.
Source
EurekAlert
Related News
•EurekAlert
Researchers Develop All-Optical Synapse for Neuromorphic Imaging Systems
A new artificial synapse, controlled entirely by light, enables in-sensor neuromorphic processing for more efficient and noise-resistant imaging systems.
•EurekAlert
AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.
•EurekAlert
Mayo Clinic Showcases Imaging AI and Early Cancer Detection Advances at ASCO 2026
Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.